MADEDDU, CLELIA
 Distribuzione geografica
Continente #
EU - Europa 250.147
NA - Nord America 14.248
AS - Asia 2.145
AF - Africa 30
SA - Sud America 30
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 10
Totale 266.629
Nazione #
IT - Italia 246.378
US - Stati Uniti d'America 14.173
CN - Cina 1.359
UA - Ucraina 1.244
SE - Svezia 983
SG - Singapore 434
DE - Germania 427
GB - Regno Unito 386
FI - Finlandia 339
FR - Francia 122
VN - Vietnam 90
KR - Corea 75
CA - Canada 68
IN - India 61
NL - Olanda 43
IE - Irlanda 36
RU - Federazione Russa 34
BE - Belgio 33
IR - Iran 33
ES - Italia 22
AT - Austria 20
BR - Brasile 20
EU - Europa 19
HK - Hong Kong 18
CZ - Repubblica Ceca 13
PH - Filippine 11
RO - Romania 11
TR - Turchia 10
JP - Giappone 9
PL - Polonia 9
CH - Svizzera 8
ID - Indonesia 8
AR - Argentina 7
AU - Australia 7
BG - Bulgaria 7
LT - Lituania 7
TH - Thailandia 7
GR - Grecia 6
TW - Taiwan 6
DZ - Algeria 5
EG - Egitto 5
DK - Danimarca 4
EE - Estonia 4
JO - Giordania 4
HU - Ungheria 3
IL - Israele 3
MX - Messico 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
UG - Uganda 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CM - Camerun 2
HR - Croazia 2
KE - Kenya 2
KZ - Kazakistan 2
MG - Madagascar 2
MU - Mauritius 2
MY - Malesia 2
NP - Nepal 2
PK - Pakistan 2
SA - Arabia Saudita 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BZ - Belize 1
EC - Ecuador 1
JM - Giamaica 1
LU - Lussemburgo 1
ML - Mali 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
TM - Turkmenistan 1
Totale 266.629
Città #
Cagliari 239.711
Uta 5.745
Fairfield 1.831
Woodbridge 1.738
Houston 1.198
Chandler 1.106
Ashburn 841
Boardman 826
Ann Arbor 816
Seattle 761
Nyköping 740
Wilmington 726
Jacksonville 707
Cambridge 595
Dearborn 393
Singapore 245
Nanjing 237
New York 237
Boston 194
Beijing 190
Santa Clara 169
Helsinki 148
Shanghai 128
San Diego 127
Dong Ket 90
Milan 89
Guangzhou 80
Shenyang 75
Nanchang 72
Redwood City 69
Changsha 59
London 57
Menlo Park 57
Hebei 56
Seoul 55
Los Angeles 47
Verona 47
Rome 45
Toronto 42
Tianjin 38
Jiaxing 36
Jinan 34
Norwalk 34
Brussels 31
Mountain View 30
Zhengzhou 28
Pune 27
Wuhan 26
Orange 24
Sassari 24
Dublin 21
Phoenix 21
Auburn Hills 20
Ningbo 20
Hangzhou 19
Hefei 18
Kunming 18
Vienna 17
Atlanta 16
Leawood 14
Munich 14
Washington 14
Berlin 13
Saint Petersburg 13
San Francisco 11
San Mateo 11
Taizhou 11
Amsterdam 10
Augusta 10
Hong Kong 10
Indiana 9
Salerno 9
Chicago 8
Nuremberg 8
Redmond 8
Rio de Janeiro 8
Shenzhen 8
Borås 7
Marrùbiu 7
Monmouth Junction 7
Rockville 7
Turin 7
Baltimore 6
Bangkok 6
Chiswick 6
Falls Church 6
Frankfurt am Main 6
Fuzhou 6
Islington 6
Jakarta 6
Kilburn 6
Kyjov 6
Torino 6
Winston-Salem 6
Xian 6
Brandizzo 5
Cedar Knolls 5
Detroit 5
Nürnberg 5
Paris 5
Totale 261.178
Nome #
Energy expenditure in caving 4.795
High-density lipoprotein contribute to G0-G1/S transition in Swiss NIH/3T3 fibroblasts 4.774
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.774
Energy expenditure in caving (dataset) 4.272
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.077
Endodontic infection and endothelial dysfunction are associated with different mechanisms in men and women 3.750
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.616
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.467
Effects of an adapted physical training on functional status, body composition and quality of life in persons with spinal cord injury paraplegia: a pilot study 3.331
Krill Oil supplementation modifies endocannabinoid congeners profile in cachectic advanced cancer patients 3.228
Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation 3.141
null 3.029
Systemic therapy for the treatment of endometrial cancer 2.981
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.876
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.744
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.651
Molecular-biology-driven treatment for metastatic colorectal cancer 2.641
Antimicrobial sulfonamides inhibit Herpesvirus 8 latency by impairing the MDM2-p53 complex formation 2.570
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.512
CREAM study: Clinical correlation between ipilimumab-Related colitis And intestinal Microbiote in metastatic melanoma patients 2.479
Sulfonamide compounds inhibit latent Human Herpesvirus 8 replication by interfering with MDM2-p53 complex formation 2.443
Alcohol consumption is a modifiable risk factor for breast cancer: Are women aware of this relationship? 2.433
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach 2.419
Feasibility and safety of total laparoscopic hysterectomy for huge uteri without the use of uterine manipulator: description of emblematic cases 2.372
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.337
Randomized phase III clinical trial of a combined treatment with carnitine plus celecoxib +/- megestrol acetate for patients with cancer-related anorexia/cachexia syndrome 2.335
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.255
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.235
Abdominal leiomyosarcomatosis after surgery with external morcellation for occult smooth muscle tumors of uncertain malignant potential: A case report 2.171
The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience 2.150
The cachexia score (CASCO) as a tool for staging cachectic cancer patients 2.115
Selenium is effective in inducing lymphocyte progression through cell cycle in cancer patients: potential mechanisms for its activity 2.094
The utility of fibrinogen level as a predictor of complications after laparoscopic gynecologic surgery: a prospective observational study 2.075
Validation of the CAchexia SCOre (CASCO). Staging cancer patients: The use of miniCASCO as a simplified tool 1.991
null 1.987
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 1.987
Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches 1.976
Microenvironmental M1 tumor-associated macrophage polarization influences cancer-related anemia in advanced ovarian cancer: Key role of interleukin-6 1.942
Association of endodontic infection with detection of an initial lesion to the cardiovascular system 1.882
A PET-positive rapidly growing mass of the abdominal wall after cesarean section with an unexpected diagnosis of vernix caseosa granuloma: a case report 1.880
Advances in pharmacologic strategies for cancer cachexia 1.820
Combined laparoscopic excisional surgery for synchronous endometrial and rectal adenocarcinoma in an obese woman 1.801
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia 1.778
Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report. 1.727
Krill oil to improve blood lipids status in advanced cancer patient with cachexia 1.706
null 1.699
Next generation sequencing driven successful combined treatment with laparoscopic surgery and immunotherapy for relapsed stage IVB cervical and synchronous stage IV lung cancer 1.690
Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia 1.690
Long-Term Survival in a Patient With Abdominal Sarcomatosis From Uterine Leiomyosarcoma: Role of Repeated Laparoscopic Surgery in Treatment and Follow-Up 1.668
Efficacy and safety of a two drug-combination regimen for cancer-related cachexia in the clinical practice. 1.663
Successful laparoscopic management of a giant ovarian cyst 1.660
Future prospects for PD-1 targeting, macrophage infiltration, and IDO pathway activation in patients with sarcomas 1.651
The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study 1.650
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia 1.633
A multitargeted treatment approach for anemia and cachexia in metastatic castration-resistant prostate cancer 1.615
Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results 1.603
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.591
Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy 1.588
Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia 1.576
Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects 1.522
Surgical outcome and complications of total laparoscopic hysterectomy for very large myomatous uteri in relation to uterine weight: a prospective study in a continuous series of 461 procedures 1.512
Surprising results of a supportive integrated therapy in myelofibrosis 1.509
Large twisted ovarian fibroma associated with Meigs' syndrome, abdominal pain and severe anemia treated by laparoscopic surgery 1.493
null 1.489
Defibrotide in the COVID-19 coagulopathy: what is the timing? 1.487
Laparoscopic hysterectomy as optimal approach for 5400 grams uterus with associated polycythemia: A case report 1.478
L-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer 1.474
Immunotherapy and Cancer: The Multi-Omics Perspective 1.467
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.433
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.404
Multifactorial pathogenesis of COVID-19-related coagulopathy. Can defibrotide have a role in the early phases of coagulation disorders? 1.397
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.389
An interdisciplinary approach for laparoscopic removal of a large retroperitoneal pelvic schwannoma attached to vital vessels: A case report 1.380
null 1.362
Feasibility and safety of total laparoscopic hysterectomy for uteri weighing from 1.5 kg to 11.000 kg 1.332
Editorial: Biological Mechanism-Based and Patient-Centered Management of Cancer-Related Symptoms and Syndromes 1.311
Thyroid dysfunction and ultrasonography features in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Preliminary results from a prospective cohort study. 1.267
EFFICACY AND SAFETY OF A TWO DRUG-COMBINATION REGIMEN FOR CANCER-RELATED CACHEXIA IN THE CLINICAL PRACTICE 1.238
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.232
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.216
(0) Save to: more options IMPROVEMENT OF PHYSICAL ACTIVITY AS AN ALTERNATIVE OBJECTIVE VARIABLE TO MEASURE TREATMENT EFFECTS OF ANTI CACHEXIA THERAPY IN CANCER PATIENTS 1.160
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate 1.135
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.107
Quantitative evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status 1.071
null 1.063
Risultati preliminari di uno studio di fase II con Sorafenib in pazienti anziani affetti da epatocarcinoma 1.002
null 998
Trastuzumab induced-early cardiac disfunction assessed with TDI: correlation with biological markers of chronic inflammation and oxidative stress. 987
Quantitative evaluation of oxidative stress, chronic inflammatory indexes, and leptin in cancer patients: Correlation with stage and performance status. 962
null 944
null 936
New perspective on the nutritional approach to cancer-related anorexia/cachexia: Preliminary results of a randomised phase III clinical trial with five different arms of treatment 930
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 909
Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: Comparison between elderly and non-elderly patient response 880
Blocking inflammation to improve immunotherapy of advanced cancer 880
An attempt to correlate a "Multidimensional Geriatric Assessment" (MGA), treatment assignment and clinical outcome in elderly cancer patients: results of a phase II open study 872
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients 845
Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients 836
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: A report of two cases 819
Cisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity 816
Totale 191.140
Categoria #
all - tutte 343.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 343.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202023.455 0 0 0 0 0 11.304 6.037 1.437 902 875 845 2.055
2020/202162.316 1.834 2.174 2.419 15.705 12.848 7.729 5.543 4.151 1.638 3.273 3.049 1.953
2021/202212.848 1.247 908 736 864 1.195 882 775 801 1.102 1.069 1.424 1.845
2022/202322.782 1.877 2.743 2.323 1.897 1.712 2.355 1.312 2.030 1.545 1.642 2.178 1.168
2023/202425.243 1.672 1.004 933 1.643 2.391 4.609 3.354 1.678 1.162 1.731 2.632 2.434
2024/202536.189 9.469 11.282 5.467 5.314 2.616 2.041 0 0 0 0 0 0
Totale 267.383